首页> 美国卫生研究院文献>Cell Regulation >Phospholipase A2 Antagonists Inhibit Nocodazole-induced Golgi Ministack Formation: Evidence of an ER Intermediate and Constitutive Cycling
【2h】

Phospholipase A2 Antagonists Inhibit Nocodazole-induced Golgi Ministack Formation: Evidence of an ER Intermediate and Constitutive Cycling

机译:磷脂酶A2拮抗剂抑制诺考达唑诱导的高尔基体小堆栈形成:ER中间和组成性循环的证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Evidence has been presented both for and against obligate retrograde movement of resident Golgi proteins through the endoplasmic reticulum (ER) during nocodazole-induced Golgi ministack formation. Here, we studied the nocodazole-induced formation of ministacks using phospholipase A2 (PLA2) antagonists, which have been shown previously to inhibit brefeldin A–stimulated Golgi-to-ER retrograde transport. Examination of clone 9 rat hepatocytes by immunofluorescence and immunoelectron microscopy revealed that a subset of PLA2 antagonists prevented nocodazole-induced ministack formation by inhibiting two different trafficking pathways for resident Golgi enzymes; at 25 μM, retrograde Golgi-to-ER transport was inhibited, whereas at 5 μM, Golgi-to-ER trafficking was permitted, but resident Golgi enzymes accumulated in the ER. Moreover, resident Golgi enzymes gradually redistributed from the juxtanuclear Golgi or Golgi ministacks to the ER in cells treated with these PLA2 antagonists alone. Not only was ER-to-Golgi transport of resident Golgi enzymes inhibited in cells treated with these PLA2 antagonists, but transport of the vesicular stomatitis virus G protein out of the ER was also prevented. These results support a model of obligate retrograde recycling of Golgi resident enzymes during nocodazole-induced ministack formation and provide additional evidence that resident Golgi enzymes slowly and constitutively cycle between the Golgi and ER.
机译:已有证据表明在诺考达唑诱导的高尔基体小叠层形成过程中,驻留高尔基体蛋白通过内质网(ER)逆行专性迁移的证据都存在。在这里,我们使用磷脂酶A2(PLA2)拮抗剂研究了诺考达唑诱导的小细胞叠层的形成,先前已证明它们可以抑制布雷菲德菌素A刺激的高尔基体到ER的逆行转运。通过免疫荧光和免疫电子显微镜检查克隆的9只大鼠肝细胞,发现一部分PLA2拮抗剂通过抑制驻留的高尔基酶的两种不同运输途径来阻止诺考达唑诱导的小细胞形成。在25μM时,逆行的高尔基体到ER转运受到抑制,而在5μM时,高尔基体到ER的运输被允许,但常驻高尔基体中的酶积累。此外,在单独用这些PLA2拮抗剂处理的细胞中,常驻高尔基体酶逐渐从近核高尔基体或高尔基体微栈重新分布到ER中。在用这些PLA2拮抗剂处理的细胞中,不仅内源高尔基酶从ER向高尔基体的转运受到抑制,而且还阻止了水疱性口炎病毒G蛋白从ER转运出去。这些结果支持了在诺考达唑诱导的小堆栈形成过程中高尔基驻留酶专性逆行回收的模型,并提供了其他证据,表明高尔基驻留酶在高尔基体和内质网之间缓慢而组成性循环。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号